Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
David Miklos, Stanford University
ClinicalTrials.gov Identifier:
NCT01155817
First received: June 15, 2010
Last updated: May 5, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)